Centers for Disease Control and Prevention
Team Leader, Drug-Resistant Tuberculosis
Atlanta
GAUSA
30333
Biographical Sketch: Dr Peter Cegielski received his AB in Biochemistry from Harvard University in 1978 and his MD from the University of California at San Diego in 1984. He completed a residency in internal medicine in 1987 and a fellowship in Infectious Diseases and International Health in 1990, both at Duke University Medical Center, including 2 years as a Lecturer and attending physician in the Department of Medicine at Muhimbili Medical Center in Dar es Salaam, Tanzania. He joined Duke’s faculty in 1990, and earned an MPH in epidemiology from the University of North Carolina at Chapel Hill. In 1994, Dr. Cegielski moved to the University of Texas Health Science Center at Tyler where he headed a 30-bed inpatient TB ward and consulted for 35 county health department TB clinics in northeast Texas. In 1996, Dr. Cegielski moved to Chiang Mai, Thailand to become Field Director of Johns Hopkins University's HIV/AIDS research unit at Chiang Mai University. In 1998, he joined the Division of TB Elimination (DTBE) at the US Centers for Disease Control and Prevention (CDC) in Atlanta, and in 2001 he was promoted to Team Leader for Drug-Resistant TB in the International Research and Programs Branch. Dr. Cegielski was a founding member of the Stop TB "Green Light Committee" in 2000 and its chairman from 2004-2006. Through this work, he was the first person to recognize the global emergence of extensively drug-resistant (XDR) TB and led the team that first defined and described this phenomenon. He cowrote/coedited WHO's Guidelines for the Programmatic Management of Multidrug-Resistant Tuberculosis (2006). Currently, his work focuses on rapid, inexpensive diagnostic strategies for drug-resistant TB and prevention of acquired drug resistance during treatment.